Opioids for cancer pain‐an overview of Cochrane reviews

PJ Wiffen, B Wee, S Derry, RF Bell… - Cochrane Database of …, 2017 - cochranelibrary.com
Background Pain is a common symptom with cancer, and 30% to 50% of all people with
cancer will experience moderate to severe pain that can have a major negative impact on …

[HTML][HTML] Pharmacological management of cancer pain: Novel therapeutics

CG Virgen, N Kelkar, A Tran, CM Rosa… - Biomedicine & …, 2022 - Elsevier
Patients diagnosed with cancer often experience pain during their treatment course, making
it difficult to care for themselves and continue with their activities of daily living. When cancer …

Breakthrough cancer pain: twenty-five years of study

S Mercadante, RK Portenoy - Pain, 2016 - journals.lww.com
Breakthrough cancer pain (BTcP) is an episode of severe pain that “breaks through” a
period of persistent pain at least partly controlled by a stable opioid regimen. Although …

[PDF][PDF] Pathophysiology and clinical characteristics of pain in most common locations in cancer patients

W Leppert, R Zajaczkowska, J Wordliczek… - J Physiol …, 2016 - jpp.krakow.pl
Pain is one of the most common symptoms in cancer patients, especially in advanced
disease. However, pain also accompanies a significant percentage of patients during …

[HTML][HTML] From “breakthrough” to “episodic” cancer pain? A European Association for Palliative Care Research Network Expert Delphi Survey toward a common …

ET Løhre, P Klepstad, MI Bennett, C Brunelli… - Journal of pain and …, 2016 - Elsevier
Context Cancer pain can appear with spikes of higher intensity. Breakthrough cancer pain
(BTCP) is the most common term for the transient exacerbations of pain, but the ability of the …

Pain management in patients with multiple myeloma: an update

F Coluzzi, R Rolke, S Mercadante - Cancers, 2019 - mdpi.com
Most patients with multiple myeloma (MM) suffer from chronic pain at every stage of the
natural disease process. This review focuses on the most common causes of chronic pain in …

Breakthrough cancer pain (BTcP) management: a review of international and national guidelines

AN Davies, F Elsner, MJ Filbet… - BMJ supportive & …, 2018 - spcare.bmj.com
Objective Breakthrough cancer pain (BTcP) is common and has a significant impact on the
quality of life of patients with cancer. This review compares current national/international …

Factors influencing the clinical presentation of breakthrough pain in cancer patients

S Mercadante, P Marchetti, A Cuomo, A Caraceni… - Cancers, 2018 - mdpi.com
Background: The aim of this study was to identify potential variables influencing the clinical
presentation of breakthrough cancer pain (BTP). Methods: Cancer patients with a diagnosis …

[HTML][HTML] Efficacy of aerobic and resistance exercises on cancer pain: A meta-analysis of randomised controlled trials

PD Austin, W Lee, DSJ Costa, A Ritchie, MR Lovell - Heliyon, 2024 - cell.com
Purpose To evaluate effects of aerobic and resistance exercises for cancer-related pain in
adults with and surviving cancer. Secondary objectives were to a) evaluate the effect of …

[HTML][HTML] Fentanilo: una molécula y múltiples formulaciones galénicas de trascendencia clínica en el tratamiento del dolor irruptivo oncológico

C Álamo, C Zaragozá-Arnáez… - Revista de la …, 2017 - SciELO Espana
El manejo del dolor irruptivo oncológico exige tener prevista una medicación" de rescate"
con opioides de liberación rápida. Sin embargo, pese a la existencia de medios para su …